Ispire Technology

ISPR

Market cap $112M

CVE, ISPR and KD have been added to the Zacks Rank #5 (Strong Sell) List on February 19th, 2026.

Ispire Technology Inc. (ISPR) Q2 2026 Earnings Call Transcript

Ispire Technology Inc. (ISPR) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.14 per share a year ago.

Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025 Cash   of $17.6 Million at December 31, 2025   LOS ANGELES, Feb. 6, 2026 /PRNewswire/ --  Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the second quarter of fiscal 2026, for the three months ended December 31, 2025. Fiscal Second Quarter 2026 Financial Results Revenue of $20.3 million versus $41.8 million for the second quarter of fiscal 2025.

Invitation-Only Forum Underscores FDA Recognition of IKE Tech as a Key Stakeholder and Highlights the Strategic Role of Age-Gating Technology in the Future of ENDS Regulation and Compliance LOS ANGELES, Feb. 4, 2026 /PRNewswire/ -- Ispire Technology Inc.  ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced that IKE Tech LLC  ("IKE Tech" or "IKE"), a joint venture that includes Ispire as a founding partner, has been invited by the U.S. Food and Drug Administration (FDA) to participate in its Roundtable Discussion with Small ENDS Manufacturers on Premarket Tobacco Product Application (PMTA) Submissions. The invitation-only roundtable, taking place February 10, is the first FDA forum of its kind focused on gathering direct feedback from select electronic nicotine delivery system (ENDS) manufacturers on the PMTA process.

LOS ANGELES, Feb. 3, 2026 /PRNewswire/ --  Ispire Technology Inc.  ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00 am ET on Friday, February 6, 2026, to discuss the Company's financial results for its fiscal second quarter ended December 31, 2025. To listen to the conference call, please dial in using the information below.

Company to Showcase Fully Reengineered Portfolio; Executive Team, Including Head of Sales John Monds, Available for On-Site Meetings LOS ANGELES , Nov. 26, 2025 /PRNewswire/ --  Ispire  Technology Inc.  (NASDA Q: ISPR) ("Ispire," or the "Company"), announced that it will unveil its fully reengineered cannabis product ecosystem at MJBizCon 2025 , the world's largest cannabis industry conference and trade show. Held December 2–5 at the Las Vegas Convention Center, the event will serve as the official launchpad for Ispire's next-generation hardware suite.

LOS ANGELES , Nov. 17, 2025 /PRNewswire/ -- Ispire Technology Inc.  ("Ispire" or the "Company") (NASDAQ: ISPR), an innovator in vaping technology and precision dosing, and IKE Tech LLC  ("IKE Tech"), a joint venture that includes Ispire as a founding partner, released statements following the U.S. Food and Drug Administration's (FDA) Congressional funding and directive to combat the illicit vape market. As part of the continuing resolution passed by Congress and signed by President Trump, the FDA is now required to allocate at least $200 million of its $712 million in user fees toward enforcing regulations on electronic nicotine delivery systems (ENDS).

Ispire Technology Inc. ( ISPR ) Q1 2026 Earnings Call November 6, 2025 8:00 AM EST Company Participants Philip Carlson - Managing Director of Investor Relations Michael Wang - Co-CEO & President of Aspire North America Jie Yu - Chief Financial Officer Conference Call Participants Nicholas Anderson - ROTH Capital Partners, LLC, Research Division Helen Zuanic Presentation Operator Good morning, and welcome to the Ispire Technology's Earnings Conference Call for the First Fiscal Quarter 2026. Please note, this event is being recorded.

Ispire Technology Inc. (ISPR) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.1 per share a year ago.